BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15356995)

  • 41. Effect of buagafuran on liver microsomal cytochrome P450 in rats.
    Li E; Hu JP; Wang BL; Li Y
    J Asian Nat Prod Res; 2010 May; 12(5):371-81. PubMed ID: 20496194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
    Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
    J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery of hepatic function determined by cytochrome P450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats.
    Takemura S; Minamiyama Y; Hirohashi K; Kubo S; Funae Y; Kinoshita H
    J Surg Res; 2006 Aug; 134(2):285-91. PubMed ID: 16564546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition.
    Bae SK; Lee DY; Lee AK; Kwon JW; Lee I; Chung SJ; Kim SG; Shim CK; Lee MG
    J Pharm Sci; 2004 Sep; 93(9):2388-98. PubMed ID: 15295798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
    Sakai H; Okamoto T; Kikkawa Y
    J Pharmacol Exp Ther; 1992 Oct; 263(1):381-6. PubMed ID: 1403800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats.
    Lee SY; Oh SJ; Yun KU; Kim HM; Kim BH; Lee K; Kim SK
    Arch Toxicol; 2012 Jan; 86(1):75-85. PubMed ID: 21717108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic expression of cytochrome P450 in Zucker diabetic fatty rats.
    Park SY; Kim CH; Lee JY; Jeon JS; Kim MJ; Chae SH; Kim HC; Oh SJ; Kim SK
    Food Chem Toxicol; 2016 Oct; 96():244-53. PubMed ID: 27523289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes.
    Bachmann K; He Y; Sarver JG; Peng N
    Xenobiotica; 2003 Mar; 33(3):265-76. PubMed ID: 12637244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.
    Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition.
    Yim YG; Cho MK; Kwon JW; Kim DH; Kim SG; Lee MG
    Int J Pharm; 2003 Apr; 255(1-2):1-11. PubMed ID: 12672597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decrease in hepatic CYP2C11 mRNA and increase in heme oxygenase activity after intracerebroventricular injection of bacterial endotoxin.
    Shimamoto Y; Tasaki T; Kitamura H; Hirose K; Kazusaka A; Fujita S
    J Vet Med Sci; 1999 Jun; 61(6):609-13. PubMed ID: 10423681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats.
    Yun KU; Oh SJ; Oh JM; Kang KW; Myung CS; Song GY; Kim BH; Kim SK
    Arch Toxicol; 2010 Dec; 84(12):939-46. PubMed ID: 20130842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
    Sadrieh N; Thomas PE
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):222-32. PubMed ID: 8048065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes.
    Nakajima T; Wang RS; Elovaara E; Park SS; Gelboin HV; Vainio H
    Biochem Pharmacol; 1993 Mar; 45(5):1079-85. PubMed ID: 8461037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influences of Re Du Ning Injection, a traditional Chinese medicine injection, on the CYP450 activities in rats using a cocktail method.
    Geng T; Si H; Kang D; Li Y; Huang W; Ding G; Wang Z; Bi Y; Zhang H; Xiao W
    J Ethnopharmacol; 2015 Nov; 174():426-36. PubMed ID: 26318744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
    Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of inhalation exposure to bromo-dichloromethane on specific rat CYP isoenzymes.
    Allis JW; Brown BL; Zhao G; Pegram RA
    Toxicology; 2001 Mar; 161(1-2):67-77. PubMed ID: 11295256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.